Tracheostomy Products Market

Executive Summary

Tracheostomy Products Market was valued at US $203.37 million in 2021 and is projected to grow at 4.59% CAGR over the forecast period to reach US $266.15 million by 2027. Tracheostomy Products Market represented US $17.44 million opportunity over 2019-2021 and estimated to create US $62.78 million opportunity in 2027 over 2021.

Tracheostomy Products from Consainsights analyses the Tracheostomy Products Market in the Life Sciences industry over the forecast period to 2027.

Tracheostomy Products research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Tracheostomy Products segmentation includes Type, Technique, End User, Region and Geography.

Based on the Type, the Tracheostomy Products analysis covers Tracheostomy Tubes, Tracheostomy Ventilation Accessories, Tracheostomy Cleaning Kits, Other Accessories.

In Type segment, Tracheostomy Tubes segment has highest cagr growth of 4.07%.

Based on the Technique, the Tracheostomy Products analysis covers Percutaneous Dilatational Tracheostomy, Surgical Tracheostomy.

In Technique segment, Percutaneous Dilatational Tracheostomy segment has highest cagr growth of 4.07%.

Based on the End User, the Tracheostomy Products analysis covers Hospitals & Surgical Centers, Ambulatory Care Centers, Home Care Settings, Research Laboratories & Academic Institutes.

In End User segment, Hospitals & Surgical Centers segment has highest cagr growth of 4.07%.

Based on the Region, the Tracheostomy Products analysis covers North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

In Region segment, North America segment has highest cagr growth of 4.07%.

Based on the region, the Tracheostomy Products analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Medtronic, Smiths Group PLC, TRACOE Medical GmbH, Teleflex Incorporated, Fisher & Paykel Healthcare Ltd., Andreas Fahl Medizintechnik-Vertrieb GmbH, Boston Medical Products, Inc., ConvaTec Group PLC, Cook Group, Fuji Systems Corporation, Medis Medical (Tianjin) Co. Ltd., Pulmodyne, Troge Medical GmbH, Well Lead Medical Co., Ltd., Xinxiang Huaxi Sanitary Materials Co., Ltd. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Tracheostomy Tubes segment has the highest revenue of US $93.67 million and is expected to grow at CAGR of 4.07% by 2027 Tracheostomy Tubes segment has highest cagr growth of 4.07%.

Tracheostomy Tubes

Tracheostomy Tubes segment was valued at US $85.63 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $122.58 million by 2027. Tracheostomy Tubes segment represented US $8.03 million opportunity over 2019-2021 and estimated to create US $28.91 million opportunity in 2027 over 2021.

Tracheostomy Ventilation Accessories

Tracheostomy Ventilation Accessories segment was valued at US $52.44 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $75.07 million by 2027. Tracheostomy Ventilation Accessories segment represented US $4.92 million opportunity over 2019-2021 and estimated to create US $17.71 million opportunity in 2027 over 2021.

Tracheostomy Cleaning Kits

Tracheostomy Cleaning Kits segment was valued at US $47.57 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $68.10 million by 2027. Tracheostomy Cleaning Kits segment represented US $4.46 million opportunity over 2019-2021 and estimated to create US $16.06 million opportunity in 2027 over 2021.

Other Accessories

Other Accessories segment was valued at US $0.28 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $0.40 million by 2027. Other Accessories segment represented US $0.03 million opportunity over 2019-2021 and estimated to create US $0.09 million opportunity in 2027 over 2021.

Technique

Introduction

In 2021, Percutaneous Dilatational Tracheostomy segment has the highest revenue of US $116.60 million and is expected to grow at CAGR of 4.07% by 2027 Percutaneous Dilatational Tracheostomy segment has highest cagr growth of 4.07%.

Percutaneous Dilatational Tracheostomy

Percutaneous Dilatational Tracheostomy segment was valued at US $106.60 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $152.59 million by 2027. Percutaneous Dilatational Tracheostomy segment represented US $10.00 million opportunity over 2019-2021 and estimated to create US $35.99 million opportunity in 2027 over 2021.

Surgical Tracheostomy

Surgical Tracheostomy segment was valued at US $79.33 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $113.56 million by 2027. Surgical Tracheostomy segment represented US $7.44 million opportunity over 2019-2021 and estimated to create US $26.79 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals & Surgical Centers segment has the highest revenue of US $82.52 million and is expected to grow at CAGR of 4.07% by 2027 Hospitals & Surgical Centers segment has highest cagr growth of 4.07%.

Hospitals & Surgical Centers

Hospitals & Surgical Centers segment was valued at US $75.44 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $107.99 million by 2027. Hospitals & Surgical Centers segment represented US $7.08 million opportunity over 2019-2021 and estimated to create US $25.47 million opportunity in 2027 over 2021.

Ambulatory Care Centers

Ambulatory Care Centers segment was valued at US $42.48 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $60.80 million by 2027. Ambulatory Care Centers segment represented US $3.99 million opportunity over 2019-2021 and estimated to create US $14.34 million opportunity in 2027 over 2021.

Home Care Settings

Home Care Settings segment was valued at US $34.74 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $49.73 million by 2027. Home Care Settings segment represented US $3.26 million opportunity over 2019-2021 and estimated to create US $11.73 million opportunity in 2027 over 2021.

Research Laboratories & Academic Institutes

Research Laboratories & Academic Institutes segment was valued at US $33.27 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $47.62 million by 2027. Research Laboratories & Academic Institutes segment represented US $3.12 million opportunity over 2019-2021 and estimated to create US $11.23 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $84.35 million and is expected to grow at CAGR of 4.07% by 2027 North America segment has highest cagr growth of 4.07%.

North America

North America segment was valued at US $77.12 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $110.39 million by 2027. North America segment represented US $7.24 million opportunity over 2019-2021 and estimated to create US $26.04 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $50.20 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $71.86 million by 2027. Europe segment represented US $4.71 million opportunity over 2019-2021 and estimated to create US $16.95 million opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $32.27 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $46.19 million by 2027. Asia Pacific segment represented US $3.03 million opportunity over 2019-2021 and estimated to create US $10.89 million opportunity in 2027 over 2021.

Latin America

Latin America segment was valued at US $12.48 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $17.86 million by 2027. Latin America segment represented US $1.17 million opportunity over 2019-2021 and estimated to create US $4.21 million opportunity in 2027 over 2021.

Middle East & Africa

Middle East & Africa segment was valued at US $13.86 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $19.84 million by 2027. Middle East & Africa segment represented US $1.30 million opportunity over 2019-2021 and estimated to create US $4.68 million opportunity in 2027 over 2021.